| 2.42 Data as of May 21 |  +0.05 / +2.11%Today’s Change | 1.45 Today|||52-Week Range 3.06 | +10.00% Year-to-Date |
| Previous close | 2.37 |
| Today’s open | 2.38 |
| Day’s range | 2.31 - 2.45 |
| Volume | 106,337 |
| Average volume (3 months) | 159,877 |
| Market cap | $88.0M |
| Dividend yield | -- |
| Earnings growth (last year) | +27.33% |
| Earnings growth (this year) | -155.20% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | 12.25 |
| Today’s change | Today’s % change | |
|---|---|---|
| ANTHAnthera Pharmaceutic... | +0.02 | +3.45% |
| CPIXCumberland Pharmaceu... | -0.19 | -3.93% |
| DSCODiscovery Laboratori... | -0.04 | -2.37% |
| OGENOragenics Inc | -0.07 | -2.32% |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$5.4M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
Executive Chairman & Chief Executive Officer Geoffrey Paul Kempler |
Chief Operating Officer Dianne Angus |
Corporate headquarters Parkville, Victoria (vic) |
.
